Sellas Life Sciences (SLS) falls 0.3% to $11.31
SLS shares slipped 0.3% to $11.31, ending a two-week winning streak narrative with a third straight session of losses as leukemia research circulated ahead of Regal’s final-analysis milestone.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.